Product Program year 2020 Source: CMS Open Payments

Qge031

Drug

Open in the dashboard

General payments

$35,541

24 payments

Research payments

$5,709,769

260 payments

Through program year 2020, $35,541 in general payments and $5,709,769 in research payments were reported against Qge031.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $34,860 11
2020 Research $3,677,364 131
2019 General $680 13
2019 Research $2,032,404 129

Breakdown

Who paid General payments · program years 2019–2020
  1. Novartis Pharmaceuticals Corporation $35,541 24 payments
Top recipients General payments · program year 2020
  1. Brian Berman Dermatology · Aventura, FL $4,320 12% · 1 payment
  2. April Armstrong Dermatology · Los Angeles, CA $4,320 12% · 1 payment
  3. James Jackson Pain Medicine · Louisville, KY $4,320 12% · 1 payment
  4. Boni Elewski Dermatology · Birmingham, AL $4,320 12% · 1 payment
  5. Jonathan Bernstein Allergy & Immunology · Cincinnati, OH $3,924 11% · 1 payment

The top 5 of 11 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Allergy & Immunology $14,279 41% · 4 practitioners
  2. Dermatology $12,972 37% · 4 practitioners
  3. Pain Medicine Anesthesiology $4,320 12% · 1 practitioner
  4. Allergy Allergy & Immunology $3,289 9% · 2 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. Florida $7,590 22% · 2 recipients
  2. California $4,320 12% · 1 recipient
  3. Kentucky $4,320 12% · 1 recipient
  4. Alabama $4,320 12% · 1 recipient
  5. Ohio $3,924 11% · 1 recipient

The top 5 of 10 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

24 general · 260 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record